- Home
- Publications
- Publication Search
- Publication Details
Title
Role for polo-like kinase 4 in mediation of cytokinesis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201818820
Publisher
Proceedings of the National Academy of Sciences
Online
2019-05-17
DOI
10.1073/pnas.1818820116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A homeostatic clock sets daughter centriole size in flies
- (2018) Mustafa G. Aydogan et al. JOURNAL OF CELL BIOLOGY
- Fast and furious . . . or not, Plk4 dictates the pace
- (2018) Simon Gemble et al. JOURNAL OF CELL BIOLOGY
- An ordered pattern of Ana2 phosphorylation by Plk4 is required for centriole assembly
- (2018) Tiffany A. McLamarrah et al. JOURNAL OF CELL BIOLOGY
- Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
- (2018) Masanori Kawakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CFI-400945 is not a selective cellular PLK4 inhibitor
- (2018) Karen Oegema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversible centriole depletion with an inhibitor of Polo-like kinase 4
- (2015) Y. L. Wong et al. SCIENCE
- Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
- (2014) Andrew J. Holland et al. CANCER CELL
- Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent
- (2014) Jacqueline M. Mason et al. CANCER CELL
- Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer
- (2014) D. Mouradov et al. CANCER RESEARCH
- The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1R,2S)-2-(3-((E)-4-(((cis)-2,6-Dimethylmorpholino)methyl)styryl)-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent
- (2014) Peter B. Sampson et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones as Orally Bioavailable Antitumor Agents
- (2014) Peter B. Sampson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oncogene-like induction of cellular invasion from centrosome amplification
- (2014) Susana A. Godinho et al. NATURE
- Polo-like kinases: structural variations lead to multiple functions
- (2014) Sihem Zitouni et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
- (2013) Radoslaw Laufer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular control of animal cell cytokinesis
- (2012) Juan Pablo Fededa et al. NATURE CELL BIOLOGY
- Ponatinib for Chronic Myeloid Leukemia
- (2012) John M. Goldman NEW ENGLAND JOURNAL OF MEDICINE
- The Structure of the Plk4 Cryptic Polo Box Reveals Two Tandem Polo Boxes Required for Centriole Duplication
- (2012) Lauren K. Slevin et al. STRUCTURE
- From Plk1 to Plk5
- (2011) Guillermo de Cárcer et al. CELL CYCLE
- Anaphase Catastrophe Is a Target for Cancer Therapy
- (2011) Fabrizio Galimberti et al. CLINICAL CANCER RESEARCH
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer
- (2011) Gottfried E. Konecny et al. CLINICAL CANCER RESEARCH
- Rapid and enhanced proteolytic digestion using electric-field-oriented enzyme reactor
- (2011) Yu Zhou et al. Journal of Proteomics
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional Viability Profiles of Breast Cancer
- (2011) R. Brough et al. Cancer Discovery
- Human Plk4 phosphorylates Cdc25C
- (2010) Sepal Bonni et al. CELL CYCLE
- Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
- (2010) Y. Degenhardt et al. MOLECULAR CANCER THERAPEUTICS
- Plk4 is required for cytokinesis and maintenance of chromosomal stability
- (2010) C. O. Rosario et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polo-like kinase 4: the odd one out of the family
- (2010) James E Sillibourne et al. Cell Division
- Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe
- (2009) F. Galimberti et al. CLINICAL CANCER RESEARCH
- -Tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells
- (2009) R. Kuriyama et al. JOURNAL OF CELL SCIENCE
- Autophosphorylation of Polo-like Kinase 4 and Its Role in Centriole Duplication
- (2009) James E. Sillibourne et al. MOLECULAR BIOLOGY OF THE CELL
- Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis
- (2008) P. Finetti et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started